The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Role of the NFκB-signaling pathway in cancer
Open accessAbstract
Cancer is a group of cells that malignantly grow and proliferate uncontrollably. At present, treatment modes for cancer mainly comprise surgery, chemotherapy, radiotherapy, molecularly targeted therapy, gene therapy, and immunotherapy. However, the curative effects of these treatments have been limited thus far by specific characteristics of tumors. Abnormal activation of signaling pathways is involved in tumor pathogenesis and plays critical roles in growth, progression, and relapse of cancers. Targeted therapies against effectors in oncogenic signaling have improved the outcomes of cancer patients. NFκB is an important signaling pathway involved in pathogenesis and treatment of cancers. Excessive activation of the NFκB-signaling pathway has been documented in various tumor tissues, and studies on this signaling pathway for targeted cancer therapy have become a hot topic. In this review, we update current understanding of the NFκB-signaling pathway in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Shared Principles in NF-κB Signaling
Hayden, M. S., & Ghosh, S. (2008) · Cell · doi:10.1016/j.cell.2008.01.020 · Cited by 4,494
Schreck, R., Rieber, P., & Baeuerle, P. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07761.x · Cited by 3,816
Sies, H., Berndt, C., & Jones, D. P. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-045037 · Cited by 3,520
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
Stratton, M. R., Campbell, P. J., & Futreal, P. A. (2009) · Nature · doi:10.1038/nature07943 · Cited by 3,449
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Introduction to NF-κB: players, pathways, perspectives
Gilmore, T. D. (2006) · Oncogene · doi:10.1038/sj.onc.1209954 · Cited by 2,222
A cytokine-responsive IκB kinase that activates the transcription factor NF-κB
DiDonato, J. A., Hayakawa, M., Rothwarf, D. M., Zandi, E., & Karin, M. (1997) · Nature · doi:10.1038/41493 · Cited by 2,125
Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation
Viatour, P., Merville, M.-P., Bours, V., & Chariot, A. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.11.009 · Cited by 1,496
Inflammation meets cancer, with NF-κB as the matchmaker
Ben-Neriah, Y., & Karin, M. (2011) · Nature Immunology · doi:10.1038/ni.2060 · Cited by 1,373
Zhong, H., Voll, R. E., & Ghosh, S. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80066-0 · Cited by 1,210
Non-canonical NF-κB signaling pathway
Sun, S.-C. (2011) · Cell Research · doi:10.1038/cr.2010.177 · Cited by 1,197
Baeuerle, P. A., & Baltimore, D. (1988) · Cell · doi:10.1016/0092-8674(88)90382-0 · Cited by 1,166
Is NF-κB a good target for cancer therapy? Hopes and pitfalls
Baud, V., & Karin, M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2781 · Cited by 1,061
Annunziata, C. M., Davis, R. E., Demchenko, Y., Bellamy, W., Gabrea, A., Zhan, F., Lenz, G., Hanamura, I., Wright, G., Xiao, W., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.004 · Cited by 952
Inhibiting NF-κB activation by small molecules as a therapeutic strategy
Gupta, S. C., Sundaram, C., Reuter, S., & Aggarwal, B. B. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.05.004 · Cited by 762
Limiting inflammation—the negative regulation of NF-κB and the NLRP3 inflammasome
Afonina, I. S., Zhong, Z., Karin, M., & Beyaert, R. (2017) · Nature Immunology · doi:10.1038/ni.3772 · Cited by 759
IκB-β regulates the persistent response in a biphasic activation of NF-κB
Thompson, J. E., Phillips, R. J., Erdjument-Bromage, H., Tempst, P., & Ghosh, S. (1995) · Cell · doi:10.1016/0092-8674(95)90511-1 · Cited by 751
The noncanonical NF‐κB pathway
Sun, S. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01088.x · Cited by 722
Back to the Future with Ubiquitin
Pickart, C. M. (2004) · Cell · doi:10.1016/s0092-8674(03)01074-2 · Cited by 697
Perkins, N. D. (2006) · Oncogene · doi:10.1038/sj.onc.1209937 · Cited by 674
Chemokines and chemokine receptors in leukocyte trafficking
Olson, T. S., & Ley, K. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00738.2001 · Cited by 674
Greten, F. R., Arkan, M. C., Bollrath, J., Hsu, L.-C., Goode, J., Miething, C., Göktuna, S. I., Neuenhahn, M., Fierer, J., Paxian, S., et al. (2007) · Cell · doi:10.1016/j.cell.2007.07.009 · Cited by 616
Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma
Luedde, T., Beraza, N., Kotsikoris, V., van Loo, G., Nenci, A., De Vos, R., Roskams, T., Trautwein, C., & Pasparakis, M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.12.016 · Cited by 597
Inhibitors of NF-κB signaling: 785 and counting
Gilmore, T. D., & Herscovitch, M. (2006) · Oncogene · doi:10.1038/sj.onc.1209982 · Cited by 569
NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia
Dajee, M., Lazarov, M., Zhang, J. Y., Cai, T., Green, C. L., Russell, A. J., Marinkovich, M. P., Tao, S., Lin, Q., Kubo, Y., et al. (2003) · Nature · doi:10.1038/nature01283 · Cited by 535
Sakurai, T., He, G., Matsuzawa, A., Yu, G.-Y., Maeda, S., Hardiman, G., & Karin, M. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.06.016 · Cited by 487
New Insights into the Role of Nuclear Factor-κB in Cell Growth Regulation
Chen, F., Castranova, V., & Shi, X. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61708-7 · Cited by 473
Ubiquitination in signaling to and activation of IKK
Chen, Z. J. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01108.x · Cited by 417
I kappa B epsilon, a novel member of the Ikappa B family, controls RelA and cRel NF-kappa B activity
Whiteside, S. T. (1997) · The EMBO Journal · doi:10.1093/emboj/16.6.1413 · Cited by 395
Protein post-translational modifications and regulation of pluripotency in human stem cells
Wang, Y.-C., Peterson, S. E., & Loring, J. F. (2014) · Cell Research · doi:10.1038/cr.2013.151 · Cited by 395
Soluble TREM2 induces inflammatory responses and enhances microglial survival
Zhong, L., Chen, X.-F., Wang, T., Wang, Z., Liao, C., Wang, Z., Huang, R., Wang, D., Li, X., Wu, L., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20160844 · Cited by 362
The role of ubiquitylation in immune defence and pathogen evasion
Jiang, X., & Chen, Z. J. (2012) · Nature Reviews Immunology · doi:10.1038/nri3111 · Cited by 353
Dejardin, E. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.08.007 · Cited by 344
Noncanonical NF-κB Signaling in Health and Disease
Cildir, G., Low, K. C., & Tergaonkar, V. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.03.002 · Cited by 301
Kiechl, S., Wittmann, J., Giaccari, A., Knoflach, M., Willeit, P., Bozec, A., Moschen, A. R., Muscogiuri, G., Sorice, G. P., Kireva, T., et al. (2013) · Nature Medicine · doi:10.1038/nm.3084 · Cited by 255
Levy, D., Kuo, A. J., Chang, Y., Schaefer, U., Kitson, C., Cheung, P., Espejo, A., Zee, B. M., Liu, C. L., Tangsombatvisit, S., et al. (2011) · Nature Immunology · doi:10.1038/ni.1968 · Cited by 255
Novel IKK inhibitors: β-carbolines
Castro, A. C., Dang, L. C., Soucy, F., Grenier, L., Mazdiyasni, H., Hottelet, M., Parent, L., Pien, C., Palombella, V., & Adams, J. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00408-6 · Cited by 242
Hierarchies of NF-κB target-gene regulation
Smale, S. T. (2011) · Nature Immunology · doi:10.1038/ni.2070 · Cited by 238
Intracellular Signal Transduction Pathway Proteins As Targets for Cancer Therapy
Adjei, A. A., & Hidalgo, M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.648 · Cited by 238
Regulation of NF-κB activity through lysine monomethylation of p65
Ea, C.-K., & Baltimore, D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910439106 · Cited by 236
Al-Sadi, R., Guo, S., Ye, D., Rawat, M., & Ma, T. Y. (2016) · The American Journal of Pathology · doi:10.1016/j.ajpath.2015.12.016 · Cited by 221
OTUD7B controls non-canonical NF-κB activation through deubiquitination of TRAF3
Hu, H., Brittain, G. C., Chang, J.-H., Puebla-Osorio, N., Jin, J., Zal, A., Xiao, Y., Cheng, X., Chang, M., Fu, Y.-X., et al. (2013) · Nature · doi:10.1038/nature11831 · Cited by 220
Katada, C., Yokoyama, T., Yano, T., Kaneko, K., Oda, I., Shimizu, Y., Doyama, H., Koike, T., Takizawa, K., Hirao, M., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.07.040 · Cited by 213
Late stages of T cell maturation in the thymus involve NF-κB and tonic type I interferon signaling
Xing, Y., Wang, X., Jameson, S. C., & Hogquist, K. A. (2016) · Nature Immunology · doi:10.1038/ni.3419 · Cited by 202
Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation
Li, Y., Zhou, Q.-L., Sun, W., Chandrasekharan, P., Cheng, H. S., Ying, Z., Lakshmanan, M., Raju, A., Tenen, D. G., Cheng, S.-Y., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3240 · Cited by 200
Vlantis, K., Wullaert, A., Polykratis, A., Kondylis, V., Dannappel, M., Schwarzer, R., Welz, P., Corona, T., Walczak, H., Weih, F., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.020 · Cited by 189
IκBβ acts to inhibit and activate gene expression during the inflammatory response
Rao, P., Hayden, M. S., Long, M., Scott, M. L., West, A. P., Zhang, D., Oeckinghaus, A., Lynch, C., Hoffmann, A., Baltimore, D., et al. (2010) · Nature · doi:10.1038/nature09283 · Cited by 186
Kondegowda, N. G., Fenutria, R., Pollack, I. R., Orthofer, M., Garcia-Ocaña, A., Penninger, J. M., & Vasavada, R. C. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.021 · Cited by 169
Luftig, M., Yasui, T., Soni, V., Kang, M.-S., Jacobson, N., Cahir-McFarland, E., Seed, B., & Kieff, E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2237183100 · Cited by 167
Post-Translational Modifications of the TAK1-TAB Complex
Hirata, Y., Takahashi, M., Morishita, T., Noguchi, T., & Matsuzawa, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010205 · Cited by 162
SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling
Elliott, P. R., Leske, D., Hrdinka, M., Bagola, K., Fiil, B. K., McLaughlin, S. H., Wagstaff, J. L., Volkmar, N., Christianson, J. C., Kessler, B. M., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.08.001 · Cited by 161
Linear ubiquitination: a newly discovered regulator of cell signalling
Rieser, E., Cordier, S. M., & Walczak, H. (2013) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.11.007 · Cited by 159
Kim, S.-H., Ezhilarasan, R., Phillips, E. S., Gallego‐Perez, D., Sparks, A. E., Taylor, D., Ladner, K. J., Furuta, T., Sabit, H., Chhipa, R. R., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.01.005 · Cited by 159
Kelly, P. N., Romero, D. L., Yang, Y., Shaffer, A. L., Chaudhary, D., Robinson, S., Miao, W., Rui, L., Westlin, W. F., Kapeller, R., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20151074 · Cited by 158
RIPK1 Suppresses a TRAF2-Dependent Pathway to Liver Cancer
Schneider, A. T., Gautheron, J., Feoktistova, M., Roderburg, C., Loosen, S. H., Roy, S., Benz, F., Schemmer, P., Büchler, M. W., Nachbur, U., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2016.11.009 · Cited by 155
NF-κB Directly Regulates Fas Transcription to Modulate Fas-mediated Apoptosis and Tumor Suppression
Liu, F., Bardhan, K., Yang, D., Thangaraju, M., Ganapathy, V., Waller, J. L., Liles, G. B., Lee, J. R., & Liu, K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.356279 · Cited by 155
Alternative pathways of NF-κB activation: A double-edged sword in health and disease
Xiao, G., Rabson, A. R., YOUNG, W., Qing, G., & Qu, Z. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.04.005 · Cited by 154
Kwon, H., Choi, G.-E., Ryu, S., Kwon, S. J., Kim, S. C., Booth, C., Nichols, K. E., & Kim, H. S. (2016) · Nature Communications · doi:10.1038/ncomms11686 · Cited by 153
Rad50-CARD9 interactions link cytosolic DNA sensing to IL-1β production
Roth, S., Rottach, A., Lotz-Havla, A. S., Laux, V., Muschaweckh, A., Gersting, S. W., Muntau, A. C., Hopfner, K., Jin, L., Vanness, K., et al. (2014) · Nature Immunology · doi:10.1038/ni.2888 · Cited by 147
Targeting the NF-κB Pathway in Cancer Therapy
Erstad, D. J., & Cusack, J. C. (2013) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2013.06.011 · Cited by 143
Ghosh, S., & Dass, J. F. P. (2016) · Gene · doi:10.1016/j.gene.2016.03.008 · Cited by 120
SAU, A. C., Lau, R., Cabrita, M. A., Nolan, E., Crooks, P. A., Visvader, J. E., & Pratt, M. A. C. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.05.003 · Cited by 109
Song, W., Mazzieri, R., Yang, T., & Gobe, G. C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01106 · Cited by 109
Liu, Y., Mayo, M. W., Nagji, A. S., Smith, P. W., Ramsey, C. S., Li, D., & Jones, D. R. (2011) · Oncogene · doi:10.1038/onc.2011.308 · Cited by 104
Zhang, J., Jia, L., Lin, W., Yip, Y. L., Lo, K. W., Lau, V. M. Y., Zhu, D., Tsang, C. M., Zhou, Y., Deng, W., et al. (2017) · Journal of Virology · doi:10.1128/jvi.02168-16 · Cited by 104
Self-citationSun, Y., Fan, X., Zhang, Q. H., Shi, X., Xu, G., & Zou, C. (2017) · Tumor Biology · doi:10.1177/1010428317712592 · Cited by 104
The Xenobiotic Transporter Mdr1 Enforces T Cell Homeostasis in the Presence of Intestinal Bile Acids
Cao, W., Kayama, H., Chen, M. L., Delmas, A., Sun, A., Kim, S. Y., Rangarajan, E. S., McKevitt, K., Beck, A. P., Jackson, C. B., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.11.012 · Cited by 102
NF-κB: Regulation by Methylation
Lu, T., & Stark, G. R. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1022 · Cited by 101
Targeting IKK and NF-κB for Therapy
Durand, J. K., & Baldwin, A. S. (2017) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2016.11.006 · Cited by 97
Cancer secretome and inflammation: The bright and the dark sides of NF-κB
Capece, D., Verzella, D., Tessitore, A., Alesse, E., Capalbo, C., & Zazzeroni, F. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.08.004 · Cited by 97
Wang, Y., Ren, F., Wang, Y., Feng, Y., Wang, D., Jia, B., Qiu, Y., Wang, S., Yu, J. Q., Sung, J. J. �., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt393 · Cited by 91
Feng, M., Feng, J., Chen, W., Wang, W., Wu, X., Zhang, J., Xu, F., & Lai, M. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0564-9 · Cited by 91
Günster, R. A., Matthews, S. A., Holden, D. W., & Thurston, T. L. M. (2017) · Infection and Immunity · doi:10.1128/iai.00010-17 · Cited by 88
Zanotto‐Filho, A., Gonçalves, R. M., Klafke, K., de Souza, P. O., Dillenburg, F. C., Carro, L., Gelain, D. P., & Moreira, J. C. F. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.12.015 · Cited by 77
Sater, A. A. A., Edilova, M. I., Clouthier, D., Mbanwi, A. N., Kremmer, E., & Watts, T. H. (2016) · Nature Immunology · doi:10.1038/ni.3618 · Cited by 76
Regulation of the RelA (p65) transactivation domain
O'shea, J. M., & Perkins, N. D. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360603 · Cited by 75
The Re1/NF-kappa B/I kappa B signal transduction pathway and cancer.
Gilmore, T. D. (2003) · PubMed · Cited by 74
Roadmap for biomarkers of cancer therapy cardiotoxicity
Yu, A. F., & Ky, B. (2015) · Heart · doi:10.1136/heartjnl-2015-307894 · Cited by 74
Met1‐linked ubiquitination in immune signalling
Fiil, B. K., & Gyrd‐Hansen, M. (2014) · FEBS Journal · doi:10.1111/febs.12944 · Cited by 72
Wu, Y., Huang, Y., Chang, T., & Chou, C. (2017) · International Journal of Cancer · doi:10.1002/ijc.30932 · Cited by 72
ER stress drives Lipocalin 2 upregulation in prostate cancer cells in an NF-κB-dependent manner
Mahadevan, N., Rodvold, J., Almanza, G., Fernández-Pérez, A., Wheeler, M., & Zanetti, M. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-229 · Cited by 70
Takada, H., Imadome, K., Shibayama, H., Yoshimori, M., Wang, L., Saitoh, Y., Uota, S., Yamaoka, S., Koyama, T., Shimizu, N., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174136 · Cited by 69
The functional domains of the Drosophila morphogen dorsal: evidence from the analysis of mutants.Preprint
Isoda, K., Roth, S., & Nüsslein‐Volhard, C. (1992) · Genes & Development · doi:10.1101/gad.6.4.619 · Cited by 67
Ren, L., Li, Z., Dai, C., Zhao, D., Wang, Y., Ma, C., & Liu, C. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8443 · Cited by 65
Delcourt, V., Franck, J., Leblanc, É., Narducci, F., Robin, Y. M., Gimeno, J., Quanico, J. P., Wisztorski, M., Kobeissy, F. H., Jacques, J., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.06.001 · Cited by 64
Post-translational modifications of high mobility group box 1 and cancer.
Richard, S. A., Jiang, Y., Xiang, L. H., Zhou, S., Wang, J., Su, Z., & Xu, H. (2017) · PubMed · Cited by 62
Pujari, R., Hunte, R., Thomas, R., van der Weyden, L., Rauch, D., Ratner, L., Nyborg, J. K., Ramos, J. C., Takai, Y., & Shembade, N. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004721 · Cited by 59
Wang, Y., Qin, X., Zhu, X., Chen, W., Zhang, J., & Chen, W. (2017) · Oral Oncology · doi:10.1016/j.oraloncology.2017.11.024 · Cited by 59
p100/IκBδ sequesters and inhibits NF-κB through kappaBsome formation
Tao, Z., Fusco, A. J., Huang, D.-B., Gupta, K., Kim, D. Y., Ware, C. F., Duyne, G. D. V., & Ghosh, G. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408552111 · Cited by 58
Sunami, Y., Ringelhan, M., Kókai, E., Lu, M., O’Connor, T., Lorentzen, A., Weber, A., Rodewald, A., Müllhaupt, B., Terracciano, L., et al. (2016) · Hepatology · doi:10.1002/hep.28435 · Cited by 58
Oida, K., Matsuda, A., Jung, K., Xia, Y., Jang, H., Amagai, Y., Ahn, G., Nishikawa, S., Ishizaka, S., Jensen‐Jarolim, E., et al. (2014) · Scientific Reports · doi:10.1038/srep04057 · Cited by 56
B-cell survival and development controlled by the coordination of NF-κB family members RelB and cRel
Almaden, J., Liu, Y. C., Yang, E., Otero, D. C., Birnbaum, H. A., Davis‐Turak, J., Asagiri, M., David, M., Goldrath, A. W., & Hoffmann, A. (2016) · Blood · doi:10.1182/blood-2014-10-606988 · Cited by 56
NF-κB Signaling Pathway Inhibitors as Anticancer Drug Candidates
Barbosa, M. L. D. C., da Conceição, R. A., Fraga, A. G. M., Camarinha, B., Silva, G. C. D. C., Lima, A. G. F., Cardoso, E. A., & Lione, V. D. O. F. (2016) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520616666160729112854 · Cited by 56
Atypical IκB proteins in immune cell differentiation and function
Annemann, M., Plaza-Sirvent, C., Schuster, M., Katsoulis-Dimitriou, K., Kliche, S., Schraven, B., & Schmitz, I. (2016) · Immunology Letters · doi:10.1016/j.imlet.2016.01.006 · Cited by 52
Therapeutic microRNAs targeting the NF-kappa B signaling circuits of cancers
Tong, L., Yuan, Y., & Wu, S. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.09.004 · Cited by 52
Negative regulation of RelA phosphorylation: Emerging players and their roles in cancer
Lu, X., & Yarbrough, W. G. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.09.003 · Cited by 51
Köhler, U. A., Böhm, F., Rolfs, F., Egger, M., Hornemann, T., Pasparakis, M., Weber, A., & Werner, S. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.08.033 · Cited by 50
Role of lysine methylation of NF-κB in differential gene regulation
Lu, T., Yang, M., Huang, D.-B., Han, W., Ozer, G. H., Ghosh, G., & Stark, G. R. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311770110 · Cited by 49
Kaur, S., Sharma, N., Krishn, S., Lakshmanan, I., Rachagani, S., Baine, M., Smith, L., Lele, S., Sasson, A., Guha, S., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2174 · Cited by 47
Marienfeld, R. B., Palkowitsch, L., & Ghosh, S. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00478-06 · Cited by 47
Brady, G., Haas, D. A., Farrell, P. J., Pichlmair, A., & Bowie, A. (2017) · Journal of Virology · doi:10.1128/jvi.00545-17 · Cited by 47
Post-translational control of NF-κB signaling by ubiquitination
Won, M., Byun, H. S., Park, K. A., & Hur, G. M. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0772-2 · Cited by 43
Vaisitti, T., Gaudino, F., Ouk, S., Moscvin, M., Vitale, N., Serra, S., Arruga, F., Zakrzewski, J. L., Liou, H., Allan, J. N., et al. (2017) · Haematologica · doi:10.3324/haematol.2017.173419 · Cited by 43
Characteristics of chemokine signatures elicited by EGF and TNF in ovarian cancer cells
Son, D., Kabir, S. M., Dong, Y., Lee, E.-S., & Adunyah, S. E. (2013) · Journal of Inflammation · doi:10.1186/1476-9255-10-25 · Cited by 42
Forlani, G., Abdallah, R., Accolla, R. S., & Tosi, G. (2016) · Journal of Virology · doi:10.1128/jvi.03000-15 · Cited by 40
Keogh, C. E., Scholz, C. C., Rodríguez, J., Selfridge, A. C., von Kriegsheim, A., & Cummins, E. P. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.755090 · Cited by 40
Zhong, X., Lee, H., & Surh, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.12.171 · Cited by 37
Kieser, A. (2008) · Biological Chemistry · doi:10.1515/bc.2008.144 · Cited by 36
Salazar, L., Kashiwada, T. A., Krejčí, P., Meyer, A. N., Casale, M., Hallowell, M., Wilcox, W. R., Donoghue, D. J., & Thompson, L. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086470 · Cited by 35
CFTR Controls the Activity of NF-κB by Enhancing the Degradation of TRADD
Wang, H., Cebotaru, L., Lee, H. W., Yang, Q., Pollard, B. S., Pollard, H. B., & Guggino, W. B. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000453162 · Cited by 35
Self-citationMoles, A., Butterworth, J. A., Sanchez, A. M., Hunter, J. E., Leslie, J., Sellier, H., TINIAKOS, D. G., Cockell, S., Mann, D. A., Oakley, F., et al. (2016) · Oncogene · doi:10.1038/onc.2015.526 · Cited by 34
Petersheim, D., Massaad, M. J., Lee, S., Scarselli, A., Cancrini, C., Moriya, K., Sasahara, Y., Lankester, A. C., Dorsey, M. J., Giovanni, D. D., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.05.030 · Cited by 32
ZHANG, W., YIN, G., Dai, J., et al. (2017) · Anticancer Research · doi:10.21873/anticanres.11789 · Cited by 31
Sun, F., Zhang, Y., Xu, L., Li, S., Chen, X. '., Zhang, L., Wu, Y., & Li, J. (2017) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504017x15119525209765 · Cited by 30
Synthesis and anti-tumor activity of EF24 analogues as IKKβ inhibitors
Jin, R., Chen, Q., Yao, S., Bai, E., Fu, W., Wang, L., Wang, J., Du, X., Wei, T., Xu, H., et al. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.11.077 · Cited by 27
Synthetic Biology Reveals the Uniqueness of the RIP Kinase Domain
Chirieleison, S. M., Kertesy, S. B., & Abbott, D. W. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502631 · Cited by 26
Zeng, K., Liao, L., Lv, H., Song, F., Yu, Q., Dong, X., Li, J., Jiang, Y., & Tu, P. (2015) · Scientific Reports · doi:10.1038/srep14715 · Cited by 23
Inhibition of constitutive NF-κB activity induces platelet apoptosis via ER stress
Paul, M., Kemparaju, K., & Girish, K. S. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.10.011 · Cited by 23
Aminudin, N., Richardson, J. M., & Malek, S. N. A. (2017) · Pharmacognosy Magazine · doi:10.4103/pm.pm_13_17 · Cited by 23
pVHL mediates K63-linked ubiquitination of IKKβ, leading to IKKβ inactivation.
Wang, Y., Zhao, W.-T., Gao, Q., Fan, L., Qin, Y.-Q., Zhou, H., Li, M., & Fang, J. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.09.009 · Cited by 22
Zhang, Y., Yang, B. J., Zhao, J., Li, X., Zhang, L., & Zhai, Z. (2018) · Medical Science Monitor · doi:10.12659/msm.908139 · Cited by 21
Geng, Z.-B., Wei, L.-B., Zhang, C., & Yan, X. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4492 · Cited by 20
He, H., Chang, R., Zhang, T., Yang, C., & Kong, Z. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6689 · Cited by 20
Tosello, V., Bordin, F., Yu, J., Agnusdei, V., Indraccolo, S., Basso, G., Amadori, A., & Piovan, E. (2015) · Leukemia · doi:10.1038/leu.2015.335 · Cited by 17
Sundaram, G. M., & Bramhachari, P. V. (2017) · Tumor Biology · doi:10.1177/1010428317705760 · Cited by 17
Conditional, Genetically Encoded, Small Molecule–Regulated Inhibition of NFκB Signaling in RPE Cells
Vu, K. T., Zhang, F., & Hulleman, J. D. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-22133 · Cited by 17
Sun, J., Yu, X., Wang, C., Yu, C., Li, Z., Nie, W., Xu, X., Miao, X., & Jin, X. (2017) · Medical Science Monitor · doi:10.12659/msm.899727 · Cited by 16
Briggs, L. C., Chan, A. W. E., Davis, C. A., Whitelock, N., Hotiana, H. A., Baratchian, M., Bagnéris, C., Selwood, D. L., Collins, M. K., & Barrett, T. E. (2017) · Journal of Virology · doi:10.1128/jvi.01170-17 · Cited by 15
Crocodylian nuclear factor kappa B
Merchant, M., Morkotinis, V., Hale, A. N., White, M. E., & Moran, C. (2017) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2017.07.009 · Cited by 13
ROCK activity affects IL-1-induced signaling possibly through MKK4 and p38 MAPK in Caco-2 cells
Banerjee, S., & McGee, D. W. (2016) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-016-0050-0 · Cited by 12
SHI, Z., Hu, Z., CHEN, D., HUANG, J., Fan, J., Zhou, S., WANG, X., Hu, J., & Huang, F. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4738 · Cited by 10
Expanding the Interactome of the Noncanonical NF-κB Signaling Pathway
Willmann, K. L., Sacco, R., Martins, R., Garncarz, W., Krolo, A., Knapp, S., Bennett, K. L., & Boztuǧ, K. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b01004 · Cited by 10
Kinpara, S., Ito, S., Takahata, T., Saitoh, Y., Hasegawa, A., Kijiyama, M., Utsunomiya, A., Masuda, M., Miyazaki, Y., Matsuoka, M., et al. (2014) · Leukemia · doi:10.1038/leu.2015.1 · Cited by 8
A New Alpha in Line Between KRAS and NF-κB Activation?
Pak, C., & Miyamoto, S. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0193 · Cited by 8
Novel functions of chromatin-bound IκBα in oncogenic transformation
Espinosa, L., Bigas, A., & Mulero, M. C. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.84 · Cited by 6
Cited by
Macrophages in immunoregulation and therapeutics
Chen, S., Saeed, A. F. U. H., Liu, Q., Jiang, Q., Xu, H., Xiao, G. G., Rao, L., & Duo, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01452-1 · Cited by 2,229
The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
Huang, Y., Hong, W., & Wei, X. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01347-8 · Cited by 1,032
Life, death, and autophagy in cancer: NF-κB turns up everywhere
Verzella, D., Pescatore, A., Capece, D., Vecchiotti, D., Ursini, M. V., Franzoso, G., Alesse, E., & Zazzeroni, F. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2399-y · Cited by 344
The Role of Macrophages in Cancer Development and Therapy
Cendrowicz, E., Sas, Z., Bremer, E., & Rygiel, T. P. (2021) · Cancers · doi:10.3390/cancers13081946 · Cited by 332
Targeted degradation of transcription factors by TRAFTACs: TRAnscription Factor TArgeting Chimeras
Samarasinghe, K. T. G., Jaime-Figueroa, S., Burgess, M., Nalawansha, D. A., Dai, K., Hu, Z., Bebenek, A., Holley, S. A., & Crews, C. M. (2021) · Cell Chemical Biology · doi:10.1016/j.chembiol.2021.03.011 · Cited by 182
Metadata
- Authors
- Xia, L., Tan, S., Zhou, Y., Lin, J., Wang, H., Oyang, L., Tian, Y., Liu, L., Su, M., Wang, H., Cao, D., & Liao, Q.
- Venue
- OncoTargets and Therapy
- Publisher
- Informa UK Limited
- Published
- 2018-04
- Volume
- Volume 11
- Pages
- 2063-2073
- ISSN
- 1178-6930 (ISSN-L)
- OpenAlex
- W2798140734
- Cited by
- 460
- References
- 139
- FWCI
- 8.06
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.